logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 

Equities – Your destination to connect with the growth investment community.

Buyout Speculation Boosts This Biotechnology Stock

By  +Follow June 11, 2014 8:05AM
Share:
Tickers Mentioned:

While equity markets edged lower Tuesday, one small cap stock in the biotechnology sector surged, extending its gains from previous trading sessions. Shares of Achillion Pharmaceuticals Inc. (ACHN) , a biopharmaceutical company focused on the development and commercialization of treatment for infectious diseases, have surged in early trading on Tuesday on ongoing buyout speculation.

Stock Continues to Gain Momentum

After surging more than 47% in Monday’s trading session, shares of Achillion Pharmaceuticals gained another 83% on Tuesday to close at $7.79. The trading volume of 27.15 million is more than 10 times the daily average volume of 2.66 million. With the entire trading day still left, Achillion shares could see a significant spike in volume.

Achillion Pharmaceuticals shares have now gained more than 170% in the last three trading sessions. Despite the surge, the stock is still trading below its 52-week high of $8.49. However, the surge has pushed the small cap stock above its 50-day and 200-day moving averages. The stock’s MACD has also crossed the signal line and the zero-line, which is a strong bullish signal.

Buyout Rumors Spark Rally

The rally in Achillion Pharmaceuticals shares has been sparked by rumors of a takeover. The takeover speculation began after Merck (MRK) announced the acquisition of the company’s rival Idenix Pharmaceuticals Inc. (IDIX) .

Achillion Pharmaceuticals shares have got a further boost following news that the U.S. FDA has allowed the company to conduct trials in patients with hepatitis C.

Milind Deshpande, Ph.D., President and CEO of Achillion Pharmaceuticals, noted that the company remains focused on developing regimens using ACH-3422 and ACH-3102, its second-generation Phase 2 NS5A inhibitor. Deshpande added that the second half of 2014 will feature multiple milestones in that program. 

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for ACHN
10X Trading
27 Apr 15 19:35:01
All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/dNo0psqgJU $ABBV $ACHN $BMY $ESRX $GILD $MRK
fangxiang
27 Apr 15 19:04:39
RT @dougheuringaria: Susceptibility of NS5A Mutants to ACH-3102, Ledipasvir and Daclatasvir $GILD $MRK $ABBV $ACHN http://t.co/t5UFses6z6
Rocky3
27 Apr 15 18:47:07
RT @dougheuringaria: SVR results from all-oral direct-antiviral agent (DAA) regimens $MRK. $GILD $ACHN http://t.co/bZgW96GcL4
V.S. Schulz
27 Apr 15 18:43:46
RT @dougheuringaria: SVR results from all-oral direct-antiviral agent (DAA) regimens $MRK. $GILD $ACHN http://t.co/bZgW96GcL4
dougheuring
27 Apr 15 18:43:06
SVR results from all-oral direct-antiviral agent (DAA) regimens $MRK. $GILD $ACHN http://t.co/bZgW96GcL4
dougheuring
27 Apr 15 18:42:15
Susceptibility of NS5A Mutants to ACH-3102, Ledipasvir and Daclatasvir $GILD $MRK $ABBV $ACHN http://t.co/t5UFses6z6
Stockaholics
27 Apr 15 17:52:21
We Have An Absolutely MASSIVE New Stock Pick Out! Get Early Access: http://t.co/P9qXvLUx4u $CRI $MRVL $ACHN
CashRocket
27 Apr 15 17:46:38
RT @SeekingAlpha: All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/1W07RV5Mj8 $ABBV $ACHN $BMY $ESRX $GILD …
Agustin Raya
27 Apr 15 17:42:04
RT @SeekingAlpha: All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/1W07RV5Mj8 $ABBV $ACHN $BMY $ESRX $GILD …
Your WallSt Reporter
27 Apr 15 17:24:48
MaximumPenny New Pick! The BIGGEST MJ Play of 2015 is $UBQU ! See link: http://t.co/GHbsfvaZqp $THCZ $NGCG � $CRI $MRVL $ACHN
CashRocket
27 Apr 15 17:03:43
YTD: $XBI +17% $ACHN -29%
stocks
27 Apr 15 16:43:08
@MarketWatch @stockstobuy @CNBC $CYTX $ACHN $SNTA stock of the year 2015, strong buy, accumulation under way on strong data, I'll initiate.
Healthcare Stocks
27 Apr 15 16:36:51
All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/n9wnOvU9nH $ABBV $ACHN $BMY $ESRX $GILD $MRK
Quick Stock Ideas
27 Apr 15 16:36:50
All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/pMVI37zGre $ABBV $ACHN $BMY $ESRX $GILD $MRK
Seeking Alpha
27 Apr 15 16:36:50
All You Need To Know About HCV From The EASL Conference This Weekend http://t.co/1W07RV5Mj8 $ABBV $ACHN $BMY $ESRX $GILD $MRK
Stock Dawgzz
27 Apr 15 16:25:57
Our Penny Stock Picks Gained 1472% In 2 Months! Get Access To Our New Pick: http://t.co/XxqN9Mxu5P $CRI $MRVL $ACHN
Stock Rocket
27 Apr 15 16:13:46
Our Stock Pick On $THCZ Is Up 481.54% From Our Initial Release! Major News: http://t.co/bLXWVUwpQ7 $CRI $MRVL $ACHN
dailystockplays.com
27 Apr 15 14:36:25
Wide Range Bar http://t.co/xbdpHb0PEk $BMRN $MNK $SYK $TNA $DEPO $ACHN $ISIS $IWM $HALO $FV $OPK $ACT $ALKS $ARIA $FOLD $VRX $EXEL $ARRY
dailystockplays.com
27 Apr 15 14:35:57
Stochastic Oversold http://t.co/XyQKDYLLAD $IDTI $MMM $PBI $JUNO $KERX $MNK $HBAN $TEVA $BBT $ACHN $GPS $MUR $PEP $BA $LMT $GM $OII $ALL
Alexander Benton
27 Apr 15 14:30:55
Looks like good levels to buy $SBUX $UA and $ACHN while they are down
Quartermaster
27 Apr 15 14:04:33
RT @LargeVoidBot: Popular: $MYL, $NVAX, $ACHN, $TEVA, $CLNE, $YOKU, $SLW, $GLW, $BMY, $SSYS, $COH, $MAS, $CTSH, $EXXI
Large Void Bot
27 Apr 15 14:00:35
Popular: $MYL, $NVAX, $ACHN, $TEVA, $CLNE, $YOKU, $SLW, $GLW, $BMY, $SSYS, $COH, $MAS, $CTSH, $EXXI
Momentum PR
27 Apr 15 13:48:56
10 After market #Trending Companies. $Investing #Momentum #MarketResearch $AAPL $MNKD $MYL $CLDX $IBB $VDSI $NVAX $ACHN $TEVA $DD
Stock Forums
27 Apr 15 12:10:04
ACHN Achillion Pharmaceuticals Outstanding Shares: 117,540 Last: 9.66 100 Day Avg Vol: 5,415,187 http://t.co/PeBGzL7xsz $ACHN…
Your WallSt Reporter
27 Apr 15 11:33:36
MaximumPenny New Pick! The BIGGEST MJ Play of 2015 is $UBQU ! See link: http://t.co/GHbsfvaZqp $THCZ $NGCG � $CRI $MRVL $ACHN
TradingMyway
27 Apr 15 10:45:06
Scalping $ACHN
Tee
27 Apr 15 10:08:36
RT @zbiotech: top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
shmittahcapital
27 Apr 15 09:59:43
@23aloha I m looking at $enta to fall to 30$ again to me it's cheap and so risky bio considering valuations of $achn & $rgls
Josh Franklin
27 Apr 15 09:48:25
RT @InsiderWire: $ACHN | Achillion Pharmac is down 39% since we reported $1,198,000 of insider selling on 01/23/2015. Did you ... - http://…
Market Parse
27 Apr 15 09:19:16
@Bursatilbiotech Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@MomoTrades15 Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@Bursatilbiotech Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@ZRohelier Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@TraderNdaDesert Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@Investor666 Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@GregBruno1 Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
Market Parse
27 Apr 15 09:19:15
@VedaTrade Since your tweet was sent $ACHN has dropped -3.074%. See your featured tweet on Market Parse http://t.co/YHInvBkJcO
InsiderTradingWire
27 Apr 15 09:16:46
$ACHN | Achillion Pharmac is down 39% since we reported $1,198,000 of insider selling on 01/23/2015. Did you ... - http://t.co/BTdE4rMukh
Paula Treneer
27 Apr 15 09:16:03
RT @zbiotech: top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
V
27 Apr 15 08:49:00
RT @zbiotech: top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
TradingMyway
27 Apr 15 08:46:28
RT @zbiotech: top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
Dirk Haussecker
27 Apr 15 07:47:47
RT @zbiotech: top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
zach
27 Apr 15 07:39:23
top HCV takeaways from BAR at EASL... $GILD $ACHN $MRK $ABBV http://t.co/LfPHHmFOEz
nasdaqfan
27 Apr 15 07:31:45
$JCP stock Change Click Here: http://t.co/c6sAZaZnJE Also See: $MTVX $ACHN $MMM $DATE #stockmarket #tradeideas ~
StockSpotter
27 Apr 15 07:21:58
$ACHN up 1.1% to 10.17 after bullish trade setup #stocks #options #trading http://t.co/BtvbJ2KPEI
Quantcha
27 Apr 15 07:17:59
Covered Call Alert: ACHILLION PHARMACEUTICALS $ACHN returning up to 34.83% through 18-Sep-2015 http://t.co/7fWplXG8ar
V
27 Apr 15 06:52:01
RT @zbiotech: leerink highlights relative potency of NS5As as imp to development of next gen regimens $ACHN http://t.co/UYIinZ8NXC
V
27 Apr 15 06:51:48
RT @BioRunner59: @zbiotech buying $achn and securing that 40% is peanuts compared to what it would take to do that deal
V
27 Apr 15 06:51:37
RT @MomoTrades15: @BioRunner59 @zbiotech GT2-3 data should be in $ACHN hands by now. They might be discussing it with other parties. Read t…
Biotech Supernova
27 Apr 15 06:43:51
@BioRunner59 @zbiotech GT2-3 data should be in $ACHN hands by now. They might be discussing it with other parties. Read the 10-K
				
				
By  +Follow June 11, 2014 8:05AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.